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•  To ensure a statistically significant drug effect, clinicians and pain 
researchers look to exclude high “placebo responders” before the 
intervention phase of randomized clinical trials.
•  Higher placebo response (or greater relief in the placebo group) in 
patients enrolled in randomized clinical trials is associated with higher 
baseline pain variability.
•  Previous research on this relationship does not account for confounding 
variables (pre-intervention pain and natural history of disease).
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5. Conclusions
Derive the strength of the relationship between baseline pain variability and 
relief while controlling for the effects of pre-intervention pain and natural 
history between treatment groups.
•  Longitudinal pain data were obtained from two clinical trials (Placebo I 
and Placebo II):
•  Placebo I:
•  18 Controls: 46 years ± 14
•  43 Placebo-treated patients: 46 years ± 13
•  Placebo II:
•  11 Controls: 57 years ± 12
•  32 Placebo-treated patients: 57 years ± 9
•  30 Drug-treated patients: 52 years ± 14
•  Used multiple regression model with linear contrasts to isolate treatment 
effects:
•  post ~ pre + group*sd
•  post: post-intervention score
•  pre: pre-intervention score
•  group: treatment group
•  sd: baseline pain variability
•  Obtained semi-partial correlations between baseline pain variability and 
relief from multiple regression model
•  The relationship between pain variability and relief is weak and 
inconsistent.
•  Pain variability should not be used as a univariate predictor of relief in 
any group of a clinical trial; may hold some value as a covariate to 
improve statistical efficiency if it is able to capture variance.
•  Multivariable approached can be generalized to other analyses, and 
may provide unique information relative to standard univariable 
analyses.
Figure 1. Adjusted post-intervention pain as a function of SDbaseline and group.
We fit a linear regression to each study, which modeled post-intervention pain as a function of pre-intervention pain, SDbaseline, and group. Here, we depict the 
adjusted relationship between SDbaseline and post-intervention pain (on the right) after adjusting for pre-intervention pain. In Placebo I, the “no treatment” group 
has a weak negative correlation; however, this is driven by a single data point (see Figure 2); the “placebo” group’s SDbaseline is not correlated with post-
intervention pain. In Placebo II, the “no treatment” and “placebo” groups show a weak, positive relationship whereas the “drug” group exhibits approximately no 
relationship. The raw, semi-partial correlations are included on the left.
Figure 2. Influence of individual patients on the semi-partial correlations. 
Each point represents the semi-partial correlation when patient x is removed 
from the analysis. This leave-one-out analysis reveals that in both Placebo I 
and Placebo II, there was one participant who strongly drove the results (red 
points). Removing the individual in Placebo I tends to produce semi-partial 
correlation coefficients that are much closer to zero for both groups. Removing 
the individual in Placebo II to decrease the no treatment semi-partial 
correlation and increase the placebo semi-partial correlation. In both cases, our 
conclusions are unaffected since appreciable, negative semi-partial 
correlations do not appear in the placebo groups.
